Biopharmaceutical

Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…

Synopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…

Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…

Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…

Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was…

Synopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen…

  Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study  of lead compound, AL001, being developed for…

Summary : Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology…

Summay : EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of hemolytic anemia in patients…

Summary : A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincn, Vice-President and Minister of Foreign Affairs, visited Department…